Experimental: COLONYVAQ-CRC + mFOLFOX6 or CAPOX + Nivolumab Clinical Trials

1 actively recruiting trial

Pipeline

Early 1: 1

Top Sponsors

Biogenea Pharmaceuticals Ltd.1

Indications

Colorectal Cancer Stage III1
Colorectal Cancer Stage IV1
Colorectal Cancer Metastatic1
Cancer1

Other1 trial

COLONYVAQ™, a Quantum-Classical Guided Personalized Neoantigen Vaccine for MSS Stage III Colorectal Cancer

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.